West Pharmaceutical Shuttering Montgomery, Pennsylvania, Plant
12/07/2010
"The changing landscapes in the healthcare and consumer markets we serve require that we regularly evaluate our operations and adapt to changing conditions in order to successfully compete," said Donald E. Morel Jr., West's chairman and CEO. "The plans announced today will reduce the manufacturing capacity devoted to product lines that no longer support sustainable, competitive operations. These are difficult decisions that fall most heavily on our employees in these locations, and we will be providing support that should ease the burden placed on them."
The facility produced molded plastic components and assemblies for consumer products.
Most Read
-
-
Latest Trends in the Industrial Real Estate Sector Here to Stay
Q2 2021
-
Where's the Talent: Jobs Outlook in the Fastest Growing U.S. Cities
Q2 2021
-
A New Approach to Energy Savings for Your Next Manufacturing Plant
Q2 2021
-
A Turnkey Approach to Manufacturing Location Decisions
Q2 2021
-
2021 Gold & Silver Shovel Awards Project of the Year: CREE Wolfspeed’s Wafers Key to Charging of EVs
Q2 2021
-
2020 Top States for Doing Business Showcase Their Pro-Business Environments
Q3 2020